Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced today that the U.S. Food ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Replimune (REPL) shares climbed more than 60% in the premarket on Friday after the company announced plans to resubmit a marketing application for its lead asset RP1 in the U.S., following its second ...

Replimune (REPL) won over the FDA to submit a marketing application for its lead asset RP1 for the third time despite previous rejections, thanks to the intervention of White House officials, The Wall ...

Efficient no-code solution with its own IDE for easier development.

These entrants are competing with far bigger players, including OpenAI, Anthropic, and Microsoft, that make their own ...

A threat actor has been exploiting CVE-2026-48558, a critical SimpleHelp vulnerability, to drop TaskWeaver and Djinn Stealer ...

Microsoft Threat Intelligence analyzed a cryptocurrency clipper campaign that combines clipboard theft, wallet replacement, ...

A SimpleHelp authentication flaw is being exploited to deploy Djinn Stealer, a cross-platform malware targeting cloud, ...

OpenAI has added a feature to its Codex macOS app that changes the barrier to AI-powered automation: instead of writing a prompt or configuring a workflow, a user performs a task while Codex watches, ...